GPCR Structure Therapeutics Inc. - American Depositary Shares
NASDAQ · Pharmaceuticals · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 6, 2026
$27,67
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$25,59rendah 52m
$94,90tinggi 52m
Kapitalisasi Pasar (MRQ)
$5.91B
P/E
-34.6
EPS
$-0.80
lencana Anda
Rentang 52M
$26–$95
Peringkat Analis
BUY
Target Harga
$106
P/E
-34.6
ROE
-12.3%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
GPCR Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$27.67
Kapitalisasi Pasar (MRQ)
$5.91B
P/E
-34.6
EPS
$-0.80
ROE
-12.3%
Rentang 52M
$26–$95
GPCR Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
EPS$-0.802022-12-31 → 2025-12-31
Arus Kas Bebas$-226M2023-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | GPCR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -34.6rata-rata 5T ≈-57.3 | ≈-57.3 | · | · | |
| P/B (MRQ) | 4.4rata-rata 5T ≈9.2 | ≈9.2 | 5.9 | Terlalu mahal | |
| Harga / FCF (TTM) | -26.3rata-rata 5T ≈-58.2 | ≈-58.2 | · | · | |
| Harga / Arus Kas (TTM) | -26.8rata-rata 5T ≈-59.3 | ≈-59.3 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 3.9rata-rata 5T ≈9.2 | ≈9.2 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | GPCR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -11.3%rata-rata 5T ≈-20.0% | ≈-20.0% | -6.0% | Lemah | |
| ROE | -12.3%rata-rata 5T ≈-18.0% | ≈-18.0% | -12.6% | Sejajar | |
| ROIC | -11.7%rata-rata 5T ≈-17.6% | ≈-17.6% | -8.2% | Di bawah rata-rata |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | GPCR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 20.8rata-rata 5T ≈22.9 | ≈22.9 | 3.4 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 22.9rata-rata 5T ≈22.1 | ≈22.1 | 2.7 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-152.9%
Laporan Berikutnya
Nov 04, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 4, 2026 | $-0.49 | $-0.41 | -20.8% |
| 31 Maret 2026 | Mei 6, 2026 | $-0.35 | $-0.35 | 1.2% |
| 31 Des. 2025 | $-1.22 | $-0.47 | -157.1% | |
| 30 Sep. 2025 | $-1.11 | $-0.36 | -209.7% | |
| 30 Juni 2025 | $-1.08 | $-0.28 | -283.9% | |
| 31 Maret 2025 | $-0.81 | $-0.23 | -246.9% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| R&D Expense | $225M | $109M | $70M | $36M | |
| SG&A Expense | $62M | $49M | $33M | $16M | |
| Operating Expenses | $177M | $158M | $103M | $53M | |
| Operating Income | $-177M | $-158M | $-103M | $-53M | |
| Pretax Income | $-141M | $-122M | $-89M | $-51M | |
| Income Tax | $515.0K | $310.0K | $236.0K | $17.0K | |
| Net Income | $-141M | $-123M | $-90M | $-51M | |
| EPS (Basic) | $-0.80 | $-0.78 | $-0.81 | $-5.51 | |
| EPS (Diluted) | $-0.80 | $-0.78 | $-0.81 | $-5.51 | |
| Shares (Basic) | 177,596,000 | 157,922,000 | 110,198,000 | 9,584,000 | |
| Shares (Diluted) | 177,596,000 | 157,922,000 | 110,198,000 | 9,584,000 | |
| EBITDA | $-177M | $-158M | $-103M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $800M | $170M | $130M | $26M | |
| Short-term Investments | $647M | $714M | $338M | $65M | |
| Prepaid Expense | $24M | $8M | $6M | $2M | |
| Current Assets | $1.57B | $891M | $474M | $93M | |
| PP&E (Net) | $7M | $3M | $3M | $1M | |
| PP&E (Gross) | $10M | $5M | $4M | $1M | |
| Accum. Depreciation | $3M | $2M | $644.0K | $349.0K | |
| Other Non-current Assets | $717.0K | $5M | $45.0K | $3M | |
| Total Assets | $1.58B | $903M | $482M | $98M | |
| Accounts Payable | $14M | $8M | $5M | $6M | |
| Current Liabilities | $63M | $36M | $25M | $13M | |
| Capital Leases | $4M | $2M | $4M | · | |
| Other Non-current Liabilities | $647.0K | $302.0K | $298.0K | · | |
| Total Liabilities | $68M | $38M | $29M | $13M | |
| Common Stock | $21.0K | $17.0K | $14.0K | $1.0K | |
| Paid-in Capital | $1.99B | $1.19B | $659M | $2M | |
| Retained Earnings | $-470M | $-329M | $-207M | $-117M | |
| AOCI | $1M | $914.0K | $521.0K | $-110.0K | |
| Stockholders' Equity | $1.52B | $865M | $453M | $-115M | |
| Liabilities + Equity | $1.58B | $903M | $482M | $98M | |
| Shares Outstanding | 212,513,000 | 171,860,000 | 139,220,000 | 10,527,000 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $29M | $19M | $8M | $3M | |
| Operating Cash Flow | $-222M | $-117M | $-79M | $-46M | |
| CapEx | $4M | $1M | $2M | $155.0K | |
| Investing Cash Flow | $90M | $-359M | $-268M | $-62M | |
| Stock Issued | · | $515M | · | · | |
| Net Stock Activity | · | $515M | · | · | |
| Financing Cash Flow | $763M | $515M | $452M | $29M | |
| Net Change in Cash | $630M | $40M | $104M | $-79M | |
| Taxes Paid | $634.0K | $370.0K | $12.0K | · | |
| Free Cash Flow | $-226M | $-118M | $-82M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | -11.3% | -17.7% | -30.9% | · | |
| ROE | -12.3% | -13.9% | -27.8% | · | |
| ROIC | -11.7% | -18.3% | -22.8% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 24.8 | 24.7 | 19.1 | · | |
| Quick Ratio | 22.9 | 24.5 | 18.9 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $7.14 | $5.03 | $3.25 | · | |
| Cash Flow / Share | $-1.25 | $-0.74 | $-0.72 | · | |
| Cash / Share | $3.76 | $0.99 | $0.93 | · | |
| EPS (TTM) | $-0.80 | $-0.78 | $-0.81 | $-5.51 |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-141M | $-123M | $-90M | $-51M | |
| Market Cap | $14.78B | $4.66B | $5.67B | · | |
| P/E | -86.9 | -34.8 | -50.3 | · | |
| P/B | 9.7 | 5.4 | 12.5 | · | |
| P / Tangible Book | 9.7 | 5.4 | 12.5 | · | |
| P / Cash Flow | -66.5 | -40.0 | -71.4 | · | |
| P / FCF | -65.5 | -39.5 | -69.5 | · | |
| Earnings Yield | -1.1% | -2.9% | -2.0% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $100M | $67M | $69M | $59M | $55M | $43M | $33M | $33M | $22M | $21M | $18M | $19M | $13M | $8M | $9M | $10M | |
| SG&A Expense | $19M | $23M | $18M | $15M | $16M | $13M | $14M | $13M | $11M | $11M | $9M | $7M | $7M | $5M | $4M | $4M | |
| Operating Expenses | $119M | $89M | $-24M | $74M | $70M | $56M | $47M | $46M | $33M | $32M | $26M | $26M | $20M | $13M | $13M | $14M | |
| Operating Income | $-119M | $-89M | $24M | $-74M | $-70M | $-56M | $-47M | $-46M | $-33M | $-32M | $-26M | $-26M | $-20M | $-13M | $-13M | $-14M | |
| Pretax Income | $-106M | $-76M | $33M | $-66M | $-62M | $-47M | $-36M | $-34M | $-26M | $-26M | $-23M | $-23M | $-18M | $-12M | $-12M | $-14M | |
| Income Tax | $234.0K | $190.0K | $170.0K | $108.0K | $139.0K | $98.0K | $136.0K | $92.0K | $53.0K | $29.0K | $405.0K | $118.0K | $25.0K | $-180.0K | $73.0K | $64.0K | |
| Net Income | $-106M | $-76M | $33M | $-66M | $-62M | $-47M | $-36M | $-34M | $-26M | $-26M | $-24M | $-23M | $-18M | $-12M | $-12M | $-14M | |
| EPS (Basic) | $-0.49 | $-0.35 | $0.20 | $-0.37 | $-0.36 | $-0.27 | $-0.21 | $-0.20 | $-0.18 | $-0.19 | $-0.21 | $-0.20 | $-0.25 | $-1.16 | $-1.27 | $-1.64 | |
| EPS (Diluted) | $-0.49 | $-0.35 | $0.20 | $-0.37 | $-0.36 | $-0.27 | $-0.21 | $-0.20 | $-0.18 | $-0.19 | $-0.21 | $-0.20 | $-0.25 | $-1.16 | $-1.27 | $-1.64 | |
| Shares (Basic) | 217,957,000 | 217,326,000 | · | 175,469,000 | 172,647,000 | 172,051,000 | · | 171,630,000 | 148,239,000 | 139,710,000 | 114,948,000 | 114,759,000 | 71,655,000 | · | 9,780,000 | 9,435,000 | |
| Shares (Diluted) | 217,957,000 | 217,326,000 | · | 175,469,000 | 172,647,000 | 172,051,000 | · | 171,630,000 | 148,239,000 | 139,710,000 | 114,948,000 | 114,759,000 | 71,655,000 | · | 9,780,000 | 9,435,000 | |
| EBITDA | $-119M | $-89M | · | $-74M | $-70M | $-56M | · | $-46M | $-33M | $-32M | $-26M | $-26M | $-20M | · | · | · |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $273M | $316M | $800M | $103M | $147M | $152M | $170M | $172M | $382M | $98M | $51M | $41M | $126M | $26M | · | · | |
| Short-term Investments | $1.07B | $1.14B | $647M | $696M | $639M | $685M | $714M | $743M | $545M | $339M | $155M | $184M | $114M | $65M | · | · | |
| Prepaid Expense | $29M | $32M | $24M | $15M | $13M | $13M | $8M | $8M | $11M | $13M | $5M | $4M | $5M | $2M | · | · | |
| Current Assets | $1.37B | $1.49B | $1.57B | $814M | $799M | $850M | $891M | $924M | $938M | $449M | $210M | $228M | $246M | $93M | · | · | |
| PP&E (Net) | $6M | $6M | $7M | $5M | $3M | $4M | $3M | $4M | $3M | $3M | $2M | $1M | $961.0K | $1M | · | · | |
| PP&E (Gross) | · | · | $10M | · | · | · | $5M | $5M | $4M | $4M | $3M | $2M | $1M | $1M | · | · | |
| Accum. Depreciation | · | · | $3M | · | · | · | $2M | $1M | $1M | $866.0K | $572.0K | $493.0K | $419.0K | $349.0K | · | · | |
| Other Non-current Assets | $41M | $6M | $717.0K | $7M | $6M | $6M | $5M | $2M | $2M | $47.0K | $350.0K | $38.0K | $59.0K | $3M | · | · | |
| Total Assets | $1.43B | $1.51B | $1.58B | $832M | $816M | $867M | $903M | $933M | $947M | $457M | $216M | $229M | $247M | $98M | · | · | |
| Accounts Payable | $11M | $8M | $14M | $18M | $9M | $9M | $8M | $8M | $2M | $7M | $3M | $6M | $5M | $6M | · | · | |
| Current Liabilities | $66M | $57M | $63M | $58M | $39M | $36M | $36M | $33M | $23M | $24M | $20M | $15M | $11M | $13M | · | · | |
| Capital Leases | $4M | $3M | $4M | $4M | $5M | $5M | $2M | $3M | $3M | $4M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | $1M | $863.0K | $647.0K | $325.0K | $317.0K | $308.0K | $302.0K | $309.0K | $293.0K | $296.0K | $281.0K | · | · | · | · | · | |
| Total Liabilities | $71M | $61M | $68M | $62M | $44M | $42M | $38M | $36M | $26M | $27M | $23M | $15M | $11M | $13M | · | · | |
| Common Stock | $21.0K | $21.0K | $21.0K | $18.0K | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $14.0K | · | · | $11.0K | $1.0K | · | · | |
| Paid-in Capital | $2.01B | $2.00B | $1.99B | $1.27B | $1.21B | $1.20B | $1.19B | $1.19B | $1.18B | $663M | $375M | $373M | $371M | $2M | · | · | |
| Retained Earnings | $-652M | $-546M | $-470M | $-503M | $-438M | $-376M | $-329M | $-293M | $-259M | $-233M | $-182M | $-158M | $-135M | $-117M | · | · | |
| AOCI | $-3M | $-2M | $1M | $825.0K | $362.0K | $815.0K | $914.0K | $3M | $-487.0K | $-90.0K | $-310.0K | $-390.0K | $147.0K | $-110.0K | · | · | |
| Stockholders' Equity | $1.35B | $1.45B | $1.52B | $770M | $772M | $825M | $865M | $897M | $921M | $430M | $193M | $214M | $236M | $-115M | · | · | |
| Liabilities + Equity | $1.43B | $1.51B | $1.58B | $832M | $816M | $867M | $903M | $933M | $947M | $457M | $216M | $229M | $247M | $98M | · | · | |
| Shares Outstanding | 213,655,000 | 213,208,000 | 212,513,000 | 182,033,000 | 172,700,000 | 172,610,000 | 171,860,000 | 171,762,000 | 171,589,000 | 139,855,000 | · | · | 114,730,000 | 10,527,000 | · | · |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $12M | $8M | $7M | $8M | $6M | $6M | $6M | $4M | $3M | $2M | $2M | $3M | $623.0K | $628.0K | $643.0K | |
| Operating Cash Flow | $-120M | $15M | $-64M | $-51M | $-55M | $-52M | $-36M | $-20M | $-26M | $-34M | $-21M | $-17M | $-20M | $-12M | $-10M | $-10M | |
| CapEx | $-42.0K | $1M | $1M | $2M | $232.0K | $314.0K | $16.0K | $685.0K | $427.0K | $162.0K | $820.0K | · | · | $71.0K | $72.0K | $-53.0K | |
| Investing Cash Flow | $74M | $-497M | $56M | $-49M | $49M | $34M | $33M | $-189M | $-205M | $1M | $30M | $-69M | $-49M | $10M | $-17M | $-16M | |
| Stock Issued | · | · | · | · | · | · | · | $0 | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $-2M | $705M | $56M | $517.0K | $809.0K | $615.0K | $-757.0K | $515M | $702.0K | $473.0K | $-297.0K | $170M | $-316.0K | $-259.0K | $31M | |
| Net Change in Cash | $-44M | $-483M | $697M | $-44M | $-5M | $-17M | $-3M | $-209M | $284M | $-32M | $10M | $-86M | $100M | $-2M | $-27M | $5M | |
| Free Cash Flow | · | $14M | · | · | · | $-53M | · | · | · | $-34M | · | · | · | · | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -9.5% | -6.4% | · | -7.4% | -7.0% | -7.1% | · | -5.9% | -4.4% | -7.4% | -22.1% | · | -14.5% | · | · | · | |
| ROE | -10.0% | -6.7% | · | -7.9% | -7.3% | -7.5% | · | -6.2% | -4.6% | -7.8% | -24.7% | · | -15.2% | · | · | · | |
| ROIC | -8.8% | -6.2% | · | -9.6% | -9.2% | -6.8% | · | -5.1% | -3.6% | -7.5% | -13.8% | -12.2% | -8.3% | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 20.8 | 26.2 | · | 14.2 | 20.5 | 23.3 | · | 27.6 | 41.4 | 19.1 | 10.5 | 15.2 | 22.4 | · | · | · | |
| Quick Ratio | 20.3 | 25.6 | · | 13.9 | 20.1 | 22.9 | · | 27.4 | 40.9 | 18.5 | 10.2 | 15.0 | 21.9 | · | · | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.34 | $6.79 | · | $4.23 | $4.47 | $4.78 | · | $5.22 | $5.37 | $3.07 | · | · | $2.06 | · | · | · | |
| Cash Flow / Share | · | $0.07 | · | · | · | $-0.30 | · | · | · | $-0.24 | · | · | $-0.28 | · | · | · | |
| Cash / Share | $1.28 | $1.48 | · | $0.57 | $0.85 | $0.88 | · | $1.00 | $2.22 | $0.70 | · | · | $1.10 | · | · | · | |
| EPS (TTM) | $-1.01 | $-0.88 | · | $-1.21 | $-1.04 | $-0.86 | · | $-0.72 | $-0.73 | $-0.75 | $-1.82 | $-2.88 | $-4.32 | · | · | · |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-215M | $-170M | · | $-211M | $-179M | $-143M | · | $-111M | $-100M | $-98M | $-77M | $-66M | $-56M | · | · | · | |
| Market Cap | $11.47B | $10.28B | · | $5.10B | $3.58B | $2.99B | · | $7.54B | $6.74B | $5.99B | · | · | $2.73B | · | · | · | |
| P/E | -53.1 | -54.8 | · | -23.1 | -19.9 | -20.1 | · | -61.0 | -53.8 | -57.1 | -27.7 | -14.4 | -5.5 | · | · | · | |
| P/B | 8.5 | 7.1 | · | 6.6 | 4.6 | 3.6 | · | 8.4 | 7.3 | 13.9 | · | · | 11.5 | · | · | · | |
| P / Tangible Book | 8.5 | 7.1 | · | 6.6 | 4.6 | 3.6 | · | 8.4 | 7.3 | 13.9 | · | · | 11.5 | · | · | · | |
| P / Cash Flow | · | 674.6 | · | · | · | -57.2 | · | · | · | -175.9 | · | · | -134.4 | · | · | · | |
| Earnings Yield | -1.9% | -1.8% | · | -4.3% | -5.0% | -5.0% | · | -1.6% | -1.9% | -1.8% | -3.6% | -6.9% | -18.2% | · | · | · |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Laba Bersih | $-141M | $-123M | $-90M | $-51M |
| EPS Dilusian | $-0.80 | $-0.78 | $-0.81 | $-5.51 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Rasio Lancar | 24.8 | 24.7 | 19.1 | · |
| Rasio Cepat | 22.9 | 24.5 | 18.9 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Arus Kas Bebas | $-226M | $-118M | $-82M | · |
Pemilik institusional (13F) 204 pengaju · $3.6B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
204
Nilai yang dipegang
$3.6B
Posisi baru
31
Posisi yang keluar
28
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 31 (-8 vs Kuartal sebelumnya) | 28 (-10 vs Kuartal sebelumnya) | 75 (+4 vs Kuartal sebelumnya) | 55 (-11 vs Kuartal sebelumnya) | -4.4M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| FMR LLC | $419.179.123 | 7.810.306 | 11,69% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $396.054.169 | 7.379.433 | 11,05% | Saham |
| Avoro Capital Advisors LLC | $351.836.637 | 6.555.555 | 9,81% | Saham |
| JANUS HENDERSON GROUP PLC | $258.260.143 | 5.354.981 | 7,20% | Saham |
| Deep Track Capital, LP | $254.399.664 | 4.740.072 | 7,10% | Saham |
| BVF INC/IL | $180.697.390 | 3.366.823 | 5,04% | Saham |
| MORGAN STANLEY | $150.632.372 | 2.806.640 | 4,20% | Saham |
| ORBIMED ADVISORS LLC | $118.578.498 | 2.209.400 | 3,31% | Saham |
| PRINCIPAL FINANCIAL GROUP INC | $94.070.254 | 1.752.753 | 2,62% | Saham |
| AMERICAN CENTURY COMPANIES INC | $90.282.956 | 1.682.179 | 2,52% | Saham |
| RTW INVESTMENTS, LP | $86.274.901 | 1.607.507 | 2,41% | Saham |
| Driehaus Capital Management LLC | $83.361.264 | 1.553.219 | 2,33% | Saham |
| BAKER BROS. ADVISORS LP | $76.883.831 | 1.432.529 | 2,14% | Saham |
| Casdin Capital, LLC | $63.062.250 | 1.175.000 | 1,76% | Saham |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $58.285.620 | 1.086.000 | 1,63% | Saham |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $55.875.837 | 1.041.100 | 1,56% | Saham |
| Siren, L.L.C. | $46.852.139 | 872.967 | 1,31% | Saham |
| Pacific Heights Asset Management LLC | $42.936.000 | 800.000 | 1,20% | Saham |
| Rock Springs Capital Management LP | $34.365.813 | 640.317 | 0,96% | Saham |
| Aberdeen Group plc | $34.344.238 | 639.915 | 0,96% | Saham |
| FRANKLIN RESOURCES INC | $31.066.308 | 578.839 | 0,87% | Saham |
| BANK OF AMERICA CORP /DE/ | $30.238.858 | 563.422 | 0,84% | Saham |
| ALLIANCEBERNSTEIN L.P. | $29.484.326 | 611.708 | 0,82% | Saham |
| BlackRock, Inc. | $27.433.368 | 511.149 | 0,77% | Saham |
| Logos Global Management LP | $26.835.000 | 500.000 | 0,75% | Saham |
| Parkman Healthcare Partners LLC | $26.065.426 | 485.661 | 0,73% | Saham |
| Davern Capital Partners, LP | $23.939.987 | 446.059 | 0,67% | Saham |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $22.476.996 | 418.800 | 0,63% | Saham |
| UBS Group AG | $20.340.179 | 378.986 | 0,57% | Saham |
| DEUTSCHE BANK AG\ | $17.811.302 | 331.867 | 0,50% | Saham |
| NEXTBio Capital Management LP | $16.771.660 | 312.496 | 0,47% | Saham |
| Catalio Capital Management, LP | $14.842.438 | 276.550 | 0,41% | Saham |
| MARSHALL WACE, LLP | $14.361.663 | 267.592 | 0,40% | Saham |
| HSG Holding Ltd | $14.279.548 | 266.062 | 0,40% | Saham |
| SEB Asset Management AB | $13.151.433 | 245.043 | 0,37% | Saham |
| GOLDMAN SACHS GROUP INC | $13.030.539 | 242.790 | 0,36% | Saham |
| AMERIPRISE FINANCIAL INC | $12.371.685 | 230.514 | 0,35% | Saham |
| NATIONAL BANK OF CANADA /FI/ | $11.581.986 | 215.800 | 0,32% | Saham |
| TWO SIGMA INVESTMENTS, LP | $10.957.053 | 204.156 | 0,31% | Saham |
| Eversept Partners, LP | $10.535.528 | 196.302 | 0,29% | Saham |
| Schonfeld Strategic Advisors LLC | $10.234.062 | 190.685 | 0,29% | Saham |
| Woodline Partners LP | $8.254.875 | 153.808 | 0,23% | Saham |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $8.218.000 | 153.119 | 0,23% | Saham |
| ArrowMark Colorado Holdings LLC | $8.081.575 | 150.579 | 0,23% | Saham |
| Susquehanna Portfolio Strategies, LLC | $7.994.039 | 148.948 | 0,22% | Saham |
| CenterBook Partners LP | $7.944.770 | 148.030 | 0,22% | Saham |
| Rhenman & Partners Asset Management AB | $7.787.517 | 145.100 | 0,22% | Saham |
| GOLDMAN SACHS GROUP INC | $7.782.150 | 145.000 | 0,22% | Opsi beli |
| B Group, Inc. | $7.513.800 | 140.000 | 0,21% | Saham |
| HighVista Strategies LLC | $7.019.177 | 130.784 | 0,20% | Saham |
Orang dalam perusahaan 19 orang dalam · 10 pejabat · 8 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Raymond C Stevens | CHIEF EXECUTIVE OFFICER | 19 Maret 2026 A | 1.401.593 | 0 | 0 | $0 |
| Jun Yoon | CHIEF FINANCIAL OFFICER | 19 Maret 2026 A | 1.401.656 | 0 | 0 | $0 |
| Matthew Lang | COO & GC | 15 April 2026 A | 184.614 | 0 | 0 | $0 |
| Crespo Blas Coll | CHIEF MEDICAL OFFICER | 21 Sep. 2026 S | 258.228 | 0 | 1 | $-144.889 |
| Xichen Lin | CHIEF SCIENTIFIC OFFICER | 1 Sep. 2026 S | 228.960 | 0 | 11 | $-1.472.329 |
| John Joseph Berrios | Chief Commercial Officer | 6 Agu 2026 A | 140.766 | 0 | 0 | $0 |
| Yingli Ma | CHIEF TECHNOLOGY OFFICER | 19 Maret 2026 A | 139.917 | 0 | 0 | $0 |
| Ashley Hall | Chief Development Officer | 19 Maret 2026 A | 155.187 | 0 | 0 | $0 |
| Mark Allen Bach | CHIEF MEDICAL OFFICER | 15 Maret 2024 A | 26.235 | 0 | 0 | $0 |
| Melita Sun Jung | Chief Business Officer | 7 Feb. 2023 P | · | 0 | 0 | $0 |
| Joanne Waldstreicher | Direktur | 17 Juni 2026 A | · | 0 | 0 | $0 |
| Angus C. Russell | Direktur | 17 Juni 2026 A | · | 0 | 0 | $0 |
| Sharon Tetlow | Direktur | 17 Juni 2026 A | · | 0 | 0 | $0 |
| Daniel G Welch | Direktur | 17 Juni 2026 A | 123.508 | 0 | 0 | $0 |
| Eric Dobmeier | Direktur | 17 Juni 2026 A | · | 0 | 0 | $0 |
| Ted W Love | Direktur | 17 Juni 2026 A | · | 0 | 0 | $0 |
| Ramy Farid | Direktur | 7 Feb. 2023 P | 3.260.495 | 0 | 0 | $0 |
| FMR LLC | Pemilik 10% | 22 Juli 2026 S | 4.769.404 | 0 | 22 | $-7.057.088 |
| FIL Ltd | · | 7 Feb. 2023 C | 624.239 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 4 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
GPCR Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 23 analis
BELI
Target median
$101.00
+265,0%
8 34,8%
Beli Kuat
13 56,5%
Beli
2 8,7%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
15 analis · 2026-10-02Target rata-rata $105.78 +282,3%
← Di bawah semua target
Harga saat ini $27.67
Rendah$70.00
Rata-rata$105.78
Tinggi$145.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| GPCR | $14.78B | -86.9 | · | · | -12.3% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| HRMY | $2.16B | 13.8 | 21.5% | 18.3% | 19.3% | 77.2% |
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| TRLV | · | · | -0.45% | -10.3% | -10.4% | 60.2% |
| TRVI | $1.61B | -39.1 | · | · | -22.4% | · |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| ANIP | $1.78B | 23.8 | 43.8% | 8.9% | 16.6% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Structure Therapeutics (GPCR) Is A Hidden Biotech Multibagger Stock To Buy Now
Yahoo Finance · 3 bulan lalu
Saham Structure Therapeutics Naik 47%, Namun Satu Dana Keluar Penuh dari Posisi $2,6 Juta
Nasdaq · 4 bulan, 3 minggu lalu
Structure Therapeutics Merosot 28% Tahun Ini Seiring Munculnya Kepemilikan Senilai $6 Juta
Nasdaq · 6 bulan, 1 minggu lalu
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 6, 2026